EVLO
Evelo Biosciences Inc
Price:  
0.32 
USD
Volume:  
712,643.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EVLO WACC - Weighted Average Cost of Capital

The WACC of Evelo Biosciences Inc (EVLO) is 8.6%.

The Cost of Equity of Evelo Biosciences Inc (EVLO) is 16,474.55%.
The Cost of Debt of Evelo Biosciences Inc (EVLO) is 5.00%.

Range Selected
Cost of equity 11,169.90% - 21,779.20% 16,474.55%
Tax rate 0.30% - 0.40% 0.35%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.4% - 9.7% 8.6%
WACC

EVLO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2427.4 3888.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 11,169.90% 21,779.20%
Tax rate 0.30% 0.40%
Debt/Equity ratio 4593.83 4593.83
Cost of debt 5.00% 5.00%
After-tax WACC 7.4% 9.7%
Selected WACC 8.6%